1. Home
  2. XYF vs EMBC Comparison

XYF vs EMBC Comparison

Compare XYF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XYF

X Financial each representing six

HOLD

Current Price

$4.85

Market Cap

190.7M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.13

Market Cap

200.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XYF
EMBC
Founded
2014
1924
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.7M
200.5M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
XYF
EMBC
Price
$4.85
$3.13
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
120.6K
2.1M
Earning Date
05-18-2026
05-05-2026
Dividend Yield
11.34%
6.88%
EPS Growth
N/A
20.90
EPS
N/A
0.67
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
$0.90
$4.64
Revenue Growth
N/A
N/A
52 Week Low
$3.30
$2.77
52 Week High
$20.36
$15.55

Technical Indicators

Market Signals
Indicator
XYF
EMBC
Relative Strength Index (RSI) 48.92 27.72
Support Level $4.48 $3.02
Resistance Level $5.11 $3.48
Average True Range (ATR) 0.22 0.17
MACD -0.01 0.15
Stochastic Oscillator 23.19 17.31

Price Performance

Historical Comparison
XYF
EMBC

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: